Auvi-Q
Auvi-Q is a prescription medical device used for the emergency self-administration of epinephrine during severe allergic reactions (anaphylaxis). It features a compact design with audio instructions that guide the user through the injection process.
Dosage by Body Weight
Dosage is determined by body weight. Administer intramuscularly or subcutaneously into the anterolateral aspect of the thigh (outer thigh), through clothing if necessary. Seek immediate emergency medical care after use.
- Body Weight
- Below 5 kg
- Dose
- Not routine
- Frequency
- Use only if prescribed
- Tracking Notes
- Safety and efficacy have not been established for patients weighing less than 7.5 kg. Use only under strict medical supervision.
- Body Weight
- 5-7 kg
- Dose
- Not routine / 0.1 mg (if prescribed)
- Frequency
- Single use (may repeat once if severe symptoms persist before emergency help arrives)
- Tracking Notes
- Auvi-Q 0.1 mg is approved for patients weighing 7.5 kg to 15 kg. For children under 7.5 kg, consult a physician.
- Body Weight
- 8-10 kg
- Dose
- 0.1 mg
- Frequency
- Single use (may repeat once if severe symptoms persist before emergency help arrives)
- Tracking Notes
- Administered using the Auvi-Q 0.1 mg auto-injector, indicated for patients weighing 7.5 kg to 15 kg.
- Body Weight
- 11-15 kg
- Dose
- 0.1 mg
- Frequency
- Single use (may repeat once if severe symptoms persist before emergency help arrives)
- Tracking Notes
- Administered using the Auvi-Q 0.1 mg auto-injector, indicated for patients weighing 7.5 kg to 15 kg.
- Body Weight
- 16-20 kg
- Dose
- 0.15 mg
- Frequency
- Single use (may repeat once if severe symptoms persist before emergency help arrives)
- Tracking Notes
- Administered using the Auvi-Q 0.15 mg auto-injector, indicated for patients weighing 15 kg to 30 kg.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not routine | Use only if prescribed | Safety and efficacy have not been established for patients weighing less than 7.5 kg. Use only under strict medical supervision. |
| 5-7 kg | Not routine / 0.1 mg (if prescribed) | Single use (may repeat once if severe symptoms persist before emergency help arrives) | Auvi-Q 0.1 mg is approved for patients weighing 7.5 kg to 15 kg. For children under 7.5 kg, consult a physician. |
| 8-10 kg | 0.1 mg | Single use (may repeat once if severe symptoms persist before emergency help arrives) | Administered using the Auvi-Q 0.1 mg auto-injector, indicated for patients weighing 7.5 kg to 15 kg. |
| 11-15 kg | 0.1 mg | Single use (may repeat once if severe symptoms persist before emergency help arrives) | Administered using the Auvi-Q 0.1 mg auto-injector, indicated for patients weighing 7.5 kg to 15 kg. |
| 16-20 kg | 0.15 mg | Single use (may repeat once if severe symptoms persist before emergency help arrives) | Administered using the Auvi-Q 0.15 mg auto-injector, indicated for patients weighing 15 kg to 30 kg. |
Formulation
InjectionAuto-Injector
Purpose
Emergency treatment of life-threatening allergic reactions (anaphylaxis) caused by allergens, exercise, or unknown triggers.
Generic Name
EpinephrineScheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.